Apollomics (APLMW) Competitors $0.03 0.00 (-4.32%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock APLMW vs. ATNFW, SXTPW, DRTSW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. Apollomics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics Apollomics (NASDAQ:APLMW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership. Does the media favor APLMW or ATNFW? In the previous week, Apollomics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment Apollomics Neutral 180 Life Sciences Neutral Which has preferable earnings & valuation, APLMW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomicsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is APLMW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryApollomics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLMW vs. The Competition Export to ExcelMetricApollomicsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$133.28M$5.67B$9.46BDividend YieldN/A3.74%4.01%4.00%P/E RatioN/A3.6928.0920.14Price / SalesN/A4,335.85416.0798.39Price / CashN/A13.1935.9658.29Price / BookN/A42.278.565.81Net IncomeN/A-$90.99M$3.24B$258.35M7 Day PerformanceN/A2.96%4.59%3.95%1 Month PerformanceN/A7.45%12.90%14.86%1 Year PerformanceN/A191.86%35.37%19.27% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMWApollomicsN/A$0.03-4.3%N/A+115.0%$0.00N/A0.0059ATNFW180 Life SciencesN/A$0.01-6.3%N/A+14.5%$0.00N/A0.007Positive NewsGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.06-5.5%N/A-12.8%$0.00$665.45K0.002News CoveragePositive NewsGap UpDRTSWAlpha Tau MedicalN/A$0.27-2.1%N/A+7.6%$0.00N/A0.0080Positive NewsBCTXWBriaCell TherapeuticsN/A$0.04+33.5%N/A-64.6%$0.00N/A0.008Positive NewsGap UpHigh Trading VolumeCDIOWCardio DiagnosticsN/A$0.01-0.7%N/A-66.0%$0.00$19.90K0.007Positive NewsCELUWCelularityN/A$0.04-20.0%N/A+197.0%$0.00$54.22M0.00220Positive NewsGap DownCEROWCERo TherapeuticsN/A$0.02+2.0%N/A+45.3%$0.00N/A0.008Positive NewsGap UpCINGWCingulateN/A$0.04+6.3%N/A+1,504.6%$0.00N/A0.0020Positive NewsGap UpCLNNWCleneN/A$0.03+13.7%N/A-1.0%$0.00$350K0.00100Positive NewsGap UpCOEPWCoeptis TherapeuticsN/A$0.02-8.3%N/A+110.8%$0.00$62.87K0.004Positive NewsGap Down Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLMW) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
